What ketamine dose and route should be used for conscious sedation in an adult with an acute shoulder dislocation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ketamine Dosing for Shoulder Dislocation Reduction in Adults

For procedural sedation in adult shoulder dislocation, administer ketamine 2 mg/kg IV as the initial dose, with the option to combine it with midazolam 0.07 mg/kg IV for enhanced sedation and reduced emergence reactions.

Recommended Dosing Protocol

Primary Approach: IV Ketamine

  • Initial dose: 2 mg/kg IV push 1
  • Titration: Administer additional 0.5 mg/kg IV boluses if sedation is inadequate 2
  • Route: Slow intravenous administration 3

Combination Therapy Options

Ketamine + Midazolam (Preferred for most patients)

  • Midazolam 0.07 mg/kg IV followed by ketamine 2 mg/kg IV 1
  • This combination provides effective sedation with no reported hallucinations or delirium in ED studies 1
  • 98% achieved adequate sedation in prospective trials 1

Ketamine + Propofol (Alternative)

  • Recent evidence suggests ketamine-propofol may offer faster onset and shorter recovery times compared to ketamine-midazolam 4
  • Higher sedation scores (RSS 4.5) and fewer adverse events including less respiratory depression 4
  • Mean procedure time 5.7 minutes, recovery time 36.3 minutes 4

Clinical Considerations

Safety Profile

Ketamine demonstrates superior safety compared to etomidate for joint reductions:

  • 100% success rate for large joint dislocations 2
  • Significantly lower rates of myoclonus (2.2% vs 45.5%), assisted ventilation needs (6.7% vs 27.3%), and desaturation <90% (0% vs 20.6%) compared to etomidate 2
  • Preserves airway reflexes and maintains cardiovascular stability 5

Titration Strategy

Approximately 47.8% of patients require additional doses for adequate sedation 2. Be prepared to:

  • Redose with 0.5 mg/kg IV increments
  • Wait 2-3 minutes between doses to assess effect
  • Monitor for adequate dissociative state before attempting reduction

Emergence Reactions

  • Occur in approximately 25% of patients, though most are pleasant or neutral 1
  • Midazolam co-administration does NOT reduce emergence reactions in controlled trials 1, but may improve patient comfort during recovery
  • Benzodiazepines can mitigate psychological phenomena like agitation or hallucinations 5

Alternative Routes (When IV Access Unavailable)

Intramuscular Administration

  • Dose: 2-5 mg/kg IM 5
  • Slower onset but effective when IV access is difficult

Nebulized Ketamine

  • Dose: 1 mg/kg via breath-actuated nebulizer 6, 7
  • Onset of action: 20 minutes 6
  • Noninvasive, titratable, opioid-sparing option 7
  • Less effective than IV route but useful for difficult access situations

Critical Pitfalls to Avoid

  1. Underdosing: Nearly half of patients need additional doses—don't hesitate to titrate 2
  2. Premature reduction attempt: Wait for adequate dissociative state (glazed stare, nystagmus)
  3. Choosing etomidate over ketamine: Etomidate has significantly higher rates of respiratory complications and myoclonus 2
  4. Dilution error: The 100 mg/mL concentration must be diluted before IV use 3

Monitoring Requirements

  • Continuous pulse oximetry
  • Blood pressure monitoring (ketamine causes sympathomimetic effects)
  • Capnography recommended but not mandatory
  • Recovery time averages 11 minutes 2
  • Advise patients not to drive or operate machinery for 24 hours 3

Evidence Quality

The recommendations are based on Level A evidence for pediatric ketamine use and Level B evidence for adult procedural sedation from ACEP guidelines 1, supplemented by prospective trials showing 98-100% success rates for orthopedic reductions 1, 2. The ketamine-midazolam combination is supported by Grade II evidence from a prospective observational trial of 70 adults 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.